Skip to main content
Clinical Trials/NCT04827927
NCT04827927
Completed
N/A

The Effect of Closed-Loop Versus Conventional Ventilation on Mechanical Power - a Multicenter Crossover Randomized Clinical Trial

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3 sites in 1 country96 target enrollmentJuly 5, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mechanical Ventilation
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment
96
Locations
3
Primary Endpoint
The amount of MP delivered with each form of invasive ventilation
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Several studies suggest fully-automated ventilation to ventilate with a lower amount of MP in unselected ICU patients, patients after cardiac surgery, and patients with and without ARDS. The current study will directly compare the amount of MP in invasively ventilated critically ill patients by calculating MP breath-by-breath, using the various equations proposed in the literature.

Detailed Description

Rationale: Mechanical ventilation can cause ventilator-induced lung injury (VILI). Lung protective ventilation, consisting of a low tidal volume (VT), a low plateau pressure (Pplateau) and a low driving pressure (ΔP) improves survival and shortens duration of ventilation in patients with acute respiratory distress syndrome (ARDS). Lung protective ventilation may also benefit critically ill patients with respiratory failure not caused by ARDS. 'Mechanical Power of ventilation' (MP), the amount of energy per time transferred from the ventilator to the respiratory system, is a summary variable that includes all the components that play a role in VILI. With fully-automated closed-loop ventilation, these components are no longer set by the operator, but under control of the algorithms in the ventilator. Objective: To compare MP under INTELLiVENT-adaptive support ventilation (ASV), a fully-automated closed-loop ventilation, with MP under conventional ventilation. Hypothesis: INTELLiVENT-ASV compared to conventional ventilation results in a lower MP. Study design: National, multicenter, crossover, randomized clinical trial. Study population: Invasively ventilated critically ill patients. Methods: The ventilator will be randomly switched between INTELLiVENT-ASV for 3 hours and conventional ventilation for 3 hours. The amount of MP is calculated using various equations proposed in the literature. Study endpoints: The primary endpoint is the amount of MP with each form of invasive ventilation. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Differences in burden and risks of the two ventilation strategies compared in the current study are not expected. Both modes of ventilation are interchangeably used as part of standard care in the participating centers. No other interventions are performed. Neither the collection of demographic and outcome data, nor the capturing of ventilation characteristics causes harm to patients.

Registry
clinicaltrials.gov
Start Date
July 5, 2021
End Date
July 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Marcus J. Schultz

Prof. Dr. Marcus J. Schultz

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility Criteria

Inclusion Criteria

  • Admitted to one of the participating ICUs;
  • Receiving invasive ventilation through a standard endotracheal (i.e., oral) tube;
  • Expected to be ventilated \> 24 hours; and
  • Ventilation is applied by a ventilator that can provide INTELLiVENT-ASV and conventional ventilation.

Exclusion Criteria

  • Age under 18 years;
  • No written informed consent;
  • Morbidly obese; and
  • Any contra-indication for use of INTELLiVENT-ASV

Outcomes

Primary Outcomes

The amount of MP delivered with each form of invasive ventilation

Time Frame: 3 hours per ventilation mode

The amount of MP delivered with INTELLiVENT-ASV and conventional ventilation

Secondary Outcomes

  • ICU-length and hospital of stay(first 28 days after start of ventilation)
  • 28 day-mortality(first 28 days after start of ventilation)
  • Driving pressure(3 hours per ventilation mode)
  • Pmax(3 hours per ventilation mode)
  • Duration of ventilation(first 28 days after start of ventilation)
  • Tidal volume(3 hours per ventilation mode)
  • Respiratory rate(3 hours per ventilation mode)

Study Sites (3)

Loading locations...

Similar Trials